2m 2m 2m 2m 2m 2m 2m
Puma Biotech (PBYI)
NASDAQ
$8.09-$0.05 (-0.61%)
Price as of Nov 11, 2026 7:30 PM EST- $420.2MMarket Cap
- 56.84%1-Year Change
- BiotechnologyIndustry
Puma Biotech (PBYI)
$8.09-$0.05 (-0.61%)
PBYI | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.14 | ||
Change | -$0.25 (-3.04%) | ||
Open | $8.35 | ||
High | $8.56 | ||
Low | $8.06 | ||
Previous Close | $8.39 | ||
Volume | 602,373 | ||
30-Day Average Volume | 446,783 | ||
1-Week Change | -20.35% | ||
1-Month Change | -20.89% | ||
1-Year Change | 56.84% | ||
3-Year Change | 132.57% | ||
5-Year Change | 126.11% | ||
Fundamentals | |||
Shares Outstanding | 51.6M | ||
Total Assets | $202.8M | ||
Market Cap | $420.2M | ||
Enterprise Value | $378.6M | ||
Period: QTR TTM FY | |||
Revenue | $54.1M | ||
Net Income | $6.0M | ||
Free Cash Flow | $14.6M | ||
EBIT | $6.3M | ||
EBITDA | $8.7M | ||
Net Working Capital | $105.7M | ||
EPS | $0.11 | ||
Enterprise Value/EBITDA | 43 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 3 | ||
P/E | 74 | ||
PEG | -2 | ||
Price/Free Cash Flow | 29 | ||
Price/Operating Cash Flow | 29 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue